Elevated Expression of Maspin mRNA as a Predictor of Survival in Stage II and III Gallbladder Cancer Cases
Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, wi...
Saved in:
Published in | Asian Pacific journal of cancer prevention : APJCP Vol. 15; no. 1; pp. 343 - 347 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Thailand
01.01.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1513-7368 2476-762X |
DOI | 10.7314/APJCP.2014.15.1.343 |
Cover
Abstract | Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, with particular attention to prognostic importance in individuals with malignancies.
This study was carried out at the Department of Surgical Gastroenterology, King George's Medical University, Lucknow, India. Gallbladder samples from normal (n=25), gall stone disease (n=25) and cancer patients (n=38) were analysed for maspin mRNA expression by semi-quantitative reverse transcriptase PCR and quantitative real time PCR. Statistical analysis was carried out using the Students t test or ANOVA. Survival analysis was conducted according to the Kaplan-Meier method and correlations were assessed using the Pearson correlation method. p<0.05 was considered statistically significant.
Significant increase (p=0.028) in expression of maspin mRNA was observed in gallbladder cancer as compared to gall stone disease, whereas no expression was found in normal tissues. Significant correlation (Pearson's coefficient(r)=-0.798, p<0.0001) was observed between relative quantification of maspin mRNA and survival of cancer patients after surgery, with significantly shorter (p=0.002) survival in patients having relative quantification >1.5 as compared to those having relative quantification <1.5. Similarly, significant differences in patient survival for maspin mRNA expression was observed for stage II (p=0.025) and III (p=0.011) cancer.
Higher expression of maspin mRNA in gallbladder cancer has prognostic significance for stage II and III cancer, which needs to be investigated further. |
---|---|
AbstractList | Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated needs to be investigated. We therefore here focused on maspin mRNA expression in normal, gall stone disease and gallbladder cancer subjects, with particular attention to prognostic importance in individuals with malignancies.
This study was carried out at the Department of Surgical Gastroenterology, King George's Medical University, Lucknow, India. Gallbladder samples from normal (n=25), gall stone disease (n=25) and cancer patients (n=38) were analysed for maspin mRNA expression by semi-quantitative reverse transcriptase PCR and quantitative real time PCR. Statistical analysis was carried out using the Students t test or ANOVA. Survival analysis was conducted according to the Kaplan-Meier method and correlations were assessed using the Pearson correlation method. p<0.05 was considered statistically significant.
Significant increase (p=0.028) in expression of maspin mRNA was observed in gallbladder cancer as compared to gall stone disease, whereas no expression was found in normal tissues. Significant correlation (Pearson's coefficient(r)=-0.798, p<0.0001) was observed between relative quantification of maspin mRNA and survival of cancer patients after surgery, with significantly shorter (p=0.002) survival in patients having relative quantification >1.5 as compared to those having relative quantification <1.5. Similarly, significant differences in patient survival for maspin mRNA expression was observed for stage II (p=0.025) and III (p=0.011) cancer.
Higher expression of maspin mRNA in gallbladder cancer has prognostic significance for stage II and III cancer, which needs to be investigated further. |
Author | Raj, Saloni Baghel, Kavita Chandra, Abhijit Kazmi, Hasan Raza Srivastava, Rajeshwar Nath |
Author_xml | – sequence: 1 givenname: Kavita surname: Baghel fullname: Baghel, Kavita – sequence: 2 givenname: Hasan Raza surname: Kazmi fullname: Kazmi, Hasan Raza – sequence: 3 givenname: Saloni surname: Raj fullname: Raj, Saloni – sequence: 4 givenname: Abhijit surname: Chandra fullname: Chandra, Abhijit – sequence: 5 givenname: Rajeshwar Nath surname: Srivastava fullname: Srivastava, Rajeshwar Nath |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24528054$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMtOwzAURC0Eog_4AiTkH0iw41eyrKJSggpUFCR21k3ioFRpUtlpBX-P29INC1azuDOjO2eEztuuNQjdUBIqRvndZPGYLsKIUB5SEdKQcXaGhhFXMlAy-jhHQyooCxST8QCNnFsRwkWsxCUaRFxEMRF8iFbTxuygNyWefm2sca7uWtxV-Ancpm7x-vV5gsFhwAtryrroO7u_Lrd2V--gwd6y7OHT4CzD0JZeMjyDpskbKEtjcQptcRBn3BW6qKBx5vpXx-j9fvqWPgTzl1mWTuZBwQTpA_-_pIwXuTSJEkVSJTk3LKpiKTgHAUXFWSUVkTxmKo5zSRQwnoPfk-eUEDZGt8fezTZfm1JvbL0G-61Po70hORoK2zlnTaWLuofeL-8t1I2mRO8B6wNgvQesqdBUe8A-y_5kT_X_pX4Asgt8cQ |
CitedBy_id | crossref_primary_10_1007_s11033_025_10293_w crossref_primary_10_1155_2014_625695 crossref_primary_10_1111_ajco_13129 crossref_primary_10_1007_s10528_016_9745_x crossref_primary_10_13105_wjma_v7_i4_142 |
Cites_doi | 10.1111/j.1477-2574.2010.00255.x 10.1159/000353133 10.1093/ije/18.1.50 10.3816/CLC.2008.n.052 10.7314/APJCP.2012.13.1.187 10.1097/CEJ.0b013e3280145e1b 10.1126/science.8290962 10.1245/s10434-010-0985-4 10.1002/path.1319 10.1002/jso.20526 10.1007/s13277-010-0056-2 10.1002/ijc.21683 10.1016/S1470-2045(03)01021-0 10.1371/journal.pone.0063581 10.1159/000132570 10.1111/j.1440-1746.2004.03355.x 10.1159/000084525 10.1186/2001-1326-2-8 10.1001/jama.1983.03340170049027 10.1023/A:1010652105532 10.1136/jcp.2005.027284 10.1038/sj.onc.1203535 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM |
DOI | 10.7314/APJCP.2014.15.1.343 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2476-762X |
EndPage | 347 |
ExternalDocumentID | 24528054 10_7314_APJCP_2014_15_1_343 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | --- .UV 23N 2WC 53G 5GY 9ZL AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV CITATION E3Z EBS EJD F5P FRJ GROUPED_DOAJ GX1 JDI OK1 OVT RPM TR2 W2D WOW CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-c350t-4766134cb6e975c9f9b4e32f86544a5acf43f6706483788b607a34ba805bb1003 |
ISSN | 1513-7368 |
IngestDate | Sat Sep 18 02:45:52 EDT 2021 Tue Jul 01 04:31:26 EDT 2025 Thu Apr 24 23:02:48 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c350t-4766134cb6e975c9f9b4e32f86544a5acf43f6706483788b607a34ba805bb1003 |
OpenAccessLink | http://society.kisti.re.kr/sv/SV_svpsbs03V.do?method=download&cn1=JAKO201417638007898 |
PMID | 24528054 |
PageCount | 5 |
ParticipantIDs | pubmed_primary_24528054 crossref_citationtrail_10_7314_APJCP_2014_15_1_343 crossref_primary_10_7314_APJCP_2014_15_1_343 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Thailand |
PublicationPlace_xml | – name: Thailand |
PublicationTitle | Asian Pacific journal of cancer prevention : APJCP |
PublicationTitleAlternate | Asian Pac J Cancer Prev |
PublicationYear | 2014 |
References | (POCPA9_2014_v15n1_343_015) 2003; 199 (POCPA9_2014_v15n1_343_027) 1994; 263 (POCPA9_2014_v15n1_343_006) 2012; 5 (POCPA9_2014_v15n1_343_011) 1989; 18 (POCPA9_2014_v15n1_343_012) 2001; 7 (POCPA9_2014_v15n1_343_022) 2011; 13 (POCPA9_2014_v15n1_343_003) 1999; 18 (POCPA9_2014_v15n1_343_016) 2001; 46 (POCPA9_2014_v15n1_343_010) 2006; 93 (POCPA9_2014_v15n1_343_013) 2006; 59 (POCPA9_2014_v15n1_343_023) 2005; 71 POCPA9_2014_v15n1_343_002 (POCPA9_2014_v15n1_343_017) 2006; 118 (POCPA9_2014_v15n1_343_019) 2004; 19 (POCPA9_2014_v15n1_343_014) 2003; 4 (POCPA9_2014_v15n1_343_009) 2008; 29 (POCPA9_2014_v15n1_343_021) 2008; 9 (POCPA9_2014_v15n1_343_005) 2010; 17 (POCPA9_2014_v15n1_343_007) 2013; 30 (POCPA9_2014_v15n1_343_026) 2000; 38 (POCPA9_2014_v15n1_343_004) 1983; 250 (POCPA9_2014_v15n1_343_020) 2002; 8 (POCPA9_2014_v15n1_343_001) 2013; 2 (POCPA9_2014_v15n1_343_008) 2010; 31 (POCPA9_2014_v15n1_343_025) 2013; 8 (POCPA9_2014_v15n1_343_018) 2008; 17 (POCPA9_2014_v15n1_343_024) 2000; 19 |
References_xml | – volume: 13 start-page: 117 year: 2011 ident: POCPA9_2014_v15n1_343_022 publication-title: HPB (Oxford) doi: 10.1111/j.1477-2574.2010.00255.x – volume: 30 start-page: 233 year: 2013 ident: POCPA9_2014_v15n1_343_007 publication-title: Dig Surg doi: 10.1159/000353133 – volume: 18 start-page: 50 year: 1989 ident: POCPA9_2014_v15n1_343_011 publication-title: Int J Epidemiol doi: 10.1093/ije/18.1.50 – volume: 9 start-page: 361 year: 2008 ident: POCPA9_2014_v15n1_343_021 publication-title: Clin Lung Cancer doi: 10.3816/CLC.2008.n.052 – ident: POCPA9_2014_v15n1_343_002 doi: 10.7314/APJCP.2012.13.1.187 – volume: 8 start-page: 2924 year: 2002 ident: POCPA9_2014_v15n1_343_020 publication-title: Clin Cancer Res – volume: 17 start-page: 9 year: 2008 ident: POCPA9_2014_v15n1_343_018 publication-title: Eur J Cancer Prev doi: 10.1097/CEJ.0b013e3280145e1b – volume: 263 start-page: 526 year: 1994 ident: POCPA9_2014_v15n1_343_027 publication-title: Science doi: 10.1126/science.8290962 – volume: 17 start-page: 1471 year: 2010 ident: POCPA9_2014_v15n1_343_005 publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-0985-4 – volume: 38 start-page: 805 year: 2000 ident: POCPA9_2014_v15n1_343_026 publication-title: Zhonghua Wai Ke Za Zhi – volume: 199 start-page: 432 year: 2003 ident: POCPA9_2014_v15n1_343_015 publication-title: J Pathol doi: 10.1002/path.1319 – volume: 93 start-page: 610 year: 2006 ident: POCPA9_2014_v15n1_343_010 publication-title: J Surg Oncol doi: 10.1002/jso.20526 – volume: 31 start-page: 471 year: 2010 ident: POCPA9_2014_v15n1_343_008 publication-title: Tumour Biol doi: 10.1007/s13277-010-0056-2 – volume: 118 start-page: 1591 year: 2006 ident: POCPA9_2014_v15n1_343_017 publication-title: Int J Cancer doi: 10.1002/ijc.21683 – volume: 4 start-page: 167 year: 2003 ident: POCPA9_2014_v15n1_343_014 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(03)01021-0 – volume: 8 start-page: 63581 year: 2013 ident: POCPA9_2014_v15n1_343_025 publication-title: Plos One doi: 10.1371/journal.pone.0063581 – volume: 5 start-page: 41 year: 2012 ident: POCPA9_2014_v15n1_343_006 publication-title: Gastrointest Cancer Res – volume: 29 start-page: 41 year: 2008 ident: POCPA9_2014_v15n1_343_009 publication-title: Tumour Biol doi: 10.1159/000132570 – volume: 19 start-page: 916 year: 2004 ident: POCPA9_2014_v15n1_343_019 publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2004.03355.x – volume: 71 start-page: 97 year: 2005 ident: POCPA9_2014_v15n1_343_023 publication-title: Digestion doi: 10.1159/000084525 – volume: 2 start-page: 8 year: 2013 ident: POCPA9_2014_v15n1_343_001 publication-title: Clin Transl Med doi: 10.1186/2001-1326-2-8 – volume: 250 start-page: 2323 year: 1983 ident: POCPA9_2014_v15n1_343_004 publication-title: JAMA doi: 10.1001/jama.1983.03340170049027 – volume: 46 start-page: 1145 year: 2001 ident: POCPA9_2014_v15n1_343_016 publication-title: Dig Dis Sci doi: 10.1023/A:1010652105532 – volume: 59 start-page: 328 year: 2006 ident: POCPA9_2014_v15n1_343_013 publication-title: J Clin Pathol doi: 10.1136/jcp.2005.027284 – volume: 19 start-page: 2398 year: 2000 ident: POCPA9_2014_v15n1_343_024 publication-title: Oncogene doi: 10.1038/sj.onc.1203535 – volume: 18 start-page: 24 year: 1999 ident: POCPA9_2014_v15n1_343_003 publication-title: Indian J Gastroenterol – volume: 7 start-page: 812 year: 2001 ident: POCPA9_2014_v15n1_343_012 publication-title: Clin Cancer Res |
SSID | ssj0045875 |
Score | 2.0188272 |
Snippet | Maspin expression is a potential prognostic factor for various malignancies but its relation with gallbladder cancer is unknown and needs to be investigated... |
SourceID | pubmed crossref |
SourceType | Index Database Enrichment Source |
StartPage | 343 |
SubjectTerms | Adolescent Adult Aged Female Gallbladder - metabolism Gallbladder Neoplasms - genetics Gallbladder Neoplasms - metabolism Gallbladder Neoplasms - mortality Gallbladder Neoplasms - pathology Gallbladder Neoplasms - surgery Gallstones - genetics Gallstones - metabolism Gene Expression Humans India Kaplan-Meier Estimate Male Middle Aged Neoplasm Staging Prognosis RNA, Messenger - metabolism Serpins - genetics Survival Rate Young Adult |
Title | Elevated Expression of Maspin mRNA as a Predictor of Survival in Stage II and III Gallbladder Cancer Cases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24528054 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2476-762X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0045875 issn: 1513-7368 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBayDhh2GfZe94IOu2XObEvy49gF2eoWCYqiBXozJD9aB64bJE4w5C_tT460bNXtimLdxQosibDNDyTFfKII-QIeQ4Kj4RaGxxZPmWuFIlWWtHMWBJmb6B1y05m3f8oPzsTZYPC7x1pa12qUbO_cV_I_WoV7oFfcJfsAzRqhcAN-g37hChqG6z_peFJmG4kh4-RXy2etNKVltSiq4eXxbA-PkZHIs0gLzM43W1TWYB02Ta0NDDXPs2EUaVYwtD9lWaoSrdFyOEZAYLNqeYZdsdpm32XL5uuXnkj0hEVbFQpxhWnHo4Ox2UT2XZ5faF7AodwUtfEJh3J7qc_Pliv8U0FuTdexnOvUdQnmp8dGqNKlzgmri2Je1P30hcN76YvW4jrM8pk-W8eYZPEX9LR9ZbqmU-uqmS7WedsL-MzhWI0CXw_Je3zkiJEzMnP7Nbdv-ULDUIS1EYqJGyExCokdETsxCHlEHru-57nd-l27fS6CpqqzeR9d4gqFfLvjSW6EQTcWNE1gc_KcPGtXJHRPw-sFGWTVS_Jk2nIuXpF5hzJ6jTJ6lVONMoooo3JFJTUow94OZRSGNCijUURBZ9BEtIcyqlFGG5S9Jqc_Jifjfas9ocNKmLBri8N3cBhPlJeFvkjCPFQ8Y24eeAJsgJBJzlnu-RD2NucWKM_2JeNKBrZQygGH8obsVFdV9o5QL0zzBDrAcQcc7IS0FeeZdL08526WO7vE7T5YnLTl6_EUlTK-R1W75KuZtNDVW-4f_lZrwgxGXgI8LH__MEEfyNNrrH8kO_VynX2C4LVWnxvQwHV2NP0Dr-aSIw |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+Expression+of+Maspin+mRNA+as+a+Predictor+of+Survival+in+Stage+II+and+III+Gallbladder+Cancer+Cases&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Baghel%2C+Kavita&rft.au=Kazmi%2C+Hasan+Raza&rft.au=Raj%2C+Saloni&rft.au=Chandra%2C+Abhijit&rft.date=2014-01-01&rft.issn=1513-7368&rft.volume=15&rft.issue=1&rft.spage=343&rft.epage=347&rft_id=info:doi/10.7314%2FAPJCP.2014.15.1.343&rft.externalDBID=n%2Fa&rft.externalDocID=10_7314_APJCP_2014_15_1_343 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1513-7368&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1513-7368&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1513-7368&client=summon |